Results 141 to 150 of about 5,915 (202)

An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer. [PDF]

Cell Rep Med, 2022
Johnson BE, Creason AL, Stommel JM, Keck JM, Parmar S, Betts CB, Blucher A, Boniface C, Bucher E, Burlingame E, Camp T, Chin K, Eng J, Estabrook J, Feiler HS, Heskett MB, Hu Z, Kolodzie A, Kong BL, Labrie M, Lee J, Leyshock P, Mitri S, Patterson J, Riesterer JL, Sivagnanam S, Somers J, Sudar D, Thibault G, Weeder BR, Zheng C, Nan X, Thompson RF, Heiser LM, Spellman PT, Thomas G, Demir E, Chang YH, Coussens LM, Guimaraes AR, Corless C, Goecks J, Bergan R, Mitri Z, Mills GB, Gray JW.   +45 more
europepmc   +1 more source

Clinical standards for drug-susceptible pulmonary TB. [PDF]

Int J Tuberc Lung Dis, 2022
Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB.   +46 more
europepmc   +1 more source

Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial. [PDF]

ESMO Open
Collet L, Noël JC, Catteau X, Ardin M, Berthet J, Ghamry-Barrin S, Treilleux I, Bengrine Lefevre L, Martinez M, Rothé F, Sotiriou C, Caux C, Dubois B, Ray-Coquard I, Le Saux O.   +14 more
europepmc   +1 more source

The Hubble Constant. [PDF]

Living Rev Relativ, 2015
Jackson N.
europepmc   +1 more source

The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably? [PDF]

EClinicalMedicine
Vidal JM, Tsiknakis N, Staaf J, Bosch A, Ehinger A, Nimeus E, Salgado R, Bai Y, Rimm DL, Hartman J, Acs B.   +10 more
europepmc   +1 more source

Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures. [PDF]

Ann Surg, 2021
Knisely A, Zhou ZN, Wu J, Huang Y, Holcomb K, Melamed A, Advincula AP, Lalwani A, Khoury-Collado F, Tergas AI, St Clair CM, Hou JY, Hershman DL, D'Alton ME, Huang YY, Wright JD.   +15 more
europepmc   +1 more source

Implementation of point of care HIV viral load monitoring for people living with HIV in low- and middle-income countries: A systematic review on implementation research outcomes. [PDF]

PLoS One
Msoka P, Swai I, Ngowi K, Reis R, Lekic A, Mmbaga BT, Hardon A, Sumari-de Boer M.   +7 more
europepmc   +1 more source

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. [PDF]

NPJ Breast Cancer, 2022
Michmerhuizen AR, Lerner LM, Pesch AM, Ward C, Schwartz R, Wilder-Romans K, Liu M, Nino C, Jungles K, Azaria R, Jelley A, Zambrana Garcia N, Harold A, Zhang A, Wharram B, Hayes DF, Rae JM, Pierce LJ, Speers CW.   +18 more
europepmc   +1 more source

Challenges to the [Formula: see text]CDM cosmology. [PDF]

Philos Trans A Math Phys Eng Sci
Efstathiou G.
europepmc   +1 more source

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa. [PDF]

mSphere, 2021
López-Pérez M, Haro-Moreno JM, Molina-Pardines C, Ventero MP, Rodríguez JC.   +4 more
europepmc   +1 more source